Search results
Found 10266 matches for
The development of new treatments for pancreatic cancer is set to be transformed by a network of pancreatic clinical trials, aiming to find the right trial for the right patient, after a £10 million investment from Cancer Research UK announced today.
Jie Yang
BVetMed, PhD Jie Yang - Group Leader - T cell immunity and immunosuppression in cancer
Matthew Jackson
DPhil, BSc (Hons) Matthew Jackson - Postdoctoral research scientist
Giulia Orlando
MSc, DPhil Giulia Orlando - Group Leader - Epigenetic Reprogramming in Cancer
Dimitris Vavoulis
BSc, MRes, MSc, PhD Dimitris Vavoulis - Computational Biologist
Rebecca Brehm
MSc Clinical Trials, BSc (Hons) Biological Sciences Rebecca Brehm - Clinical Trial Administrator - Oncology Clinical Trials Office (OCTO)